Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Titeux

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2024
Splice modulation strategy applied to deep intronic variants in <i>COL7A1</i> causing recessive dystrophic epidermolysis bullosaNathalie Pironon, Emmanuelle Bourrat, Catherine Prost, et al.
Brain Research. Molecular Brain Research|January 18, 2003
Differences in the activation of the GFAP gene promoter by prion and viral infectionsMatthias Titeux, Maria Galou, Flávia Carvalho Alcantara Gomes, et al.
The Journal of Investigative Dermatology|December 3, 2023
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis BullosaCamille Berthault, Sonia Gaucher, Olivier Gouin, et al.
The Journal of Investigative Dermatology|November 4, 2006
DNA-based prenatal diagnosis of harlequin ichthyosis and characterization of ABCA12 mutation consequencesMasashi Akiyama, Matthias Titeux, Kaori Sakai, et al.
Journal of Clinical Immunology|April 21, 2010
Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cellsSandrine Cappellesso-Fleury, Bénédicte Puissant-Lubrano, Pol-André Apoil, et al.
Experimental Neurology|October 14, 2003
Synemin expression in developing normal and pathological human retina and lensMarcel Tawk, Matthias Titeux, Catherine Fallet, et al.
Human Mutation|February 14, 2006
Recessive dystrophic epidermolysis bullosa caused by COL7A1 hemizygosity and a missense mutation with complex effects on splicingMatthias Titeux, José Enrique Mejía, Luciné Mejlumian, et al.
Cancers|July 13, 2024
Citrullinated Histone H3, a Marker for Neutrophil Extracellular Traps, Is Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma Developing in Patients with Recessive Dystrophic Epidermolysis BullosaHélène Ragot, Sonia Gaucher, Mathilde Bonnet des Claustres, et al.
Human Gene Therapy. Clinical Development|November 11, 2014
HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNAKatharina Hennig, Lars Raasch, Carolin Kolbe, et al.
Stem Cell Research & Therapy|June 27, 2026
Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatmentMathilde Bonnet des Claustres, Sonia Gaucher, Francesco Carbone, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2024
Splice modulation strategy applied to deep intronic variants in <i>COL7A1</i> causing recessive dystrophic epidermolysis bullosaNathalie Pironon, Emmanuelle Bourrat, Catherine Prost, et al.
Brain Research. Molecular Brain Research|January 18, 2003
Differences in the activation of the GFAP gene promoter by prion and viral infectionsMatthias Titeux, Maria Galou, Flávia Carvalho Alcantara Gomes, et al.
The Journal of Investigative Dermatology|December 3, 2023
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis BullosaCamille Berthault, Sonia Gaucher, Olivier Gouin, et al.
The Journal of Investigative Dermatology|November 4, 2006
DNA-based prenatal diagnosis of harlequin ichthyosis and characterization of ABCA12 mutation consequencesMasashi Akiyama, Matthias Titeux, Kaori Sakai, et al.
Journal of Clinical Immunology|April 21, 2010
Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cellsSandrine Cappellesso-Fleury, Bénédicte Puissant-Lubrano, Pol-André Apoil, et al.
Experimental Neurology|October 14, 2003
Synemin expression in developing normal and pathological human retina and lensMarcel Tawk, Matthias Titeux, Catherine Fallet, et al.
Human Mutation|February 14, 2006
Recessive dystrophic epidermolysis bullosa caused by COL7A1 hemizygosity and a missense mutation with complex effects on splicingMatthias Titeux, José Enrique Mejía, Luciné Mejlumian, et al.
Cancers|July 13, 2024
Citrullinated Histone H3, a Marker for Neutrophil Extracellular Traps, Is Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma Developing in Patients with Recessive Dystrophic Epidermolysis BullosaHélène Ragot, Sonia Gaucher, Mathilde Bonnet des Claustres, et al.
Human Gene Therapy. Clinical Development|November 11, 2014
HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNAKatharina Hennig, Lars Raasch, Carolin Kolbe, et al.
Stem Cell Research & Therapy|June 27, 2026
Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatmentMathilde Bonnet des Claustres, Sonia Gaucher, Francesco Carbone, et al.
Pageof 4